About
Our Team
Board of Directors
Scientific Advisors
Collaborations
Programs
Programs and Pipeline
X-Linked Retinoschisis
Achromatopsia
X-Linked Retinitis Pigmentosa
Optogenetics
Age-Related Macular Degeneration
Science
Clinical Trials
Patients
Welcome Patients
About Enrollment
Patient Partners
Careers
Investors
Say Hello
Text size
A
A
About
Our Team
Board of Directors
Scientific Advisors
Collaborations
Programs
Programs and Pipeline
X-Linked Retinoschisis
Achromatopsia
X-Linked Retinitis Pigmentosa
Optogenetics
Age-Related Macular Degeneration
Science
Clinical Trials
Patients
Welcome Patients
About Enrollment
Patient Partners
Careers
Investors
Say Hello
Developing Groundbreaking
HEALTHCARE SOLUTIONS FOR PATIENTS WITH RARE DISEASES.
With the patient in mind
We Design Treatments Just for You.
At AGTC we are developing genetic therapies to treat patients with rare inherited conditions. Our most advanced therapy programs are designed to restore visual function and meet the needs of patients with rare blinding conditions.
Learn more
Latest AGTC News
AGTC to Present at Upcoming Conferences
AGTC Appoints William Aliski to its Board of Directors
AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrollment Milestone
View All News
OUR PROGRAMS
At AGTC we are focused on genetic therapies that can restore visual function in patients with rare inherited conditions.
At AGTC we are focused on genetic therapies that can restore visual function in patients with rare inherited conditions. Simple activities such as riding a bike, playing outside, and even the ability to recognize a loved one in a crowd, can be impossible for patients with rare blinding conditions.

Our treatment candidates have the potential to dramatically improve visual function in patients with conditions where only palliative or no therapies exist today.
our programs
1
X-Linked Retinoschisis
2
Achromatopsia
3
X-Linked Retinitis Pigmentosa
4
Macular Degeneration
GENE THERAPY AT ITS FINEST
Genetic therapies are complex, with interdependent components that must work in harmony.
Fifteen years of gene therapy experience allows us at AGTC to design and construct all critical gene therapy elements and bring them together to develop successful treatments for patients.
Capsid Diversity
Formulation
Gene Cassette
Manufacturing
Promoter
Vector Administration
Visionary science for life changing cures.
Contact us
Join our team
About
Our Team
Board of Directors
Collaborations
Scientific Advisors
News
Programs
X-Linked Retinoschisis
Achromatopsia
X-Linked Retinitis Pigmentosa
Optogenetics
Age-Related Macular Degeneration
Technology
Gene Therapy
AAV
Orphan Indications
Patients
About Enrollment
Patient Partners
Careers
Open Positions
Our Culture
Internship
Investors
Overview
Financials
Stock Information
Investor FAQ’s
Ethics and Compliance
© agtc. All rights reserved.
×
Contact Us
I am a...
Patient
Caregiver
Healthcare Provider
Other